Longwood Capital Partners

Acuta Capital Partners as of March 31, 2019

Portfolio Holdings for Acuta Capital Partners

Acuta Capital Partners holds 32 positions in its portfolio as reported in the March 2019 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Iovance Biotherapeutics (IOVA) 13.3 $28M 2.9M 9.51
Kadmon Hldgs 9.6 $20M 7.6M 2.64
Assembly Biosciences 7.1 $15M 761k 19.69
Biohaven Pharmaceutical Holding 6.3 $13M 256k 51.47
CAS Medical Systems 6.1 $13M 5.3M 2.43
Insmed (INSM) 5.1 $11M 370k 29.07
Immunomedics 4.6 $9.6M 500k 19.21
Veracyte (VCYT) 4.5 $9.5M 382k 25.02
Dermira 4.1 $8.6M 637k 13.55
Argenx Se (ARGX) 3.8 $7.9M 64k 124.83
Cymabay Therapeutics 3.3 $6.9M 518k 13.28
Viewray (VRAYQ) 2.9 $6.0M 815k 7.39
Kalvista Pharmaceuticals (KALV) 2.8 $5.9M 206k 28.62
Enanta Pharmaceuticals (ENTA) 2.8 $5.8M 61k 95.52
Xenon Pharmaceuticals (XENE) 2.7 $5.6M 553k 10.16
IRIDEX Corporation (IRIX) 2.5 $5.4M 1.2M 4.56
Dicerna Pharmaceuticals 2.3 $4.8M 329k 14.65
Adverum Biotechnologies 2.3 $4.8M 919k 5.24
Arvinas Ord (ARVN) 2.2 $4.6M 314k 14.76
Protagonist Therapeutics (PTGX) 2.0 $4.2M 338k 12.57
Alector (ALEC) 1.8 $3.7M 200k 18.72
Acer Therapeutics 1.7 $3.6M 147k 24.30
Arrowhead Pharmaceuticals (ARWR) 1.5 $3.1M 168k 18.35
Mirati Therapeutics 1.4 $3.0M 41k 73.29
Quotient 1.2 $2.5M 280k 9.01
Amarin Corporation (AMRN) 0.9 $1.8M 88k 20.77
Gossamer Bio (GOSS) 0.6 $1.3M 60k 21.67
Allakos (ALLK) 0.3 $547k 14k 40.52
Sutro Biopharma (STRO) 0.2 $518k 46k 11.38
Chembio Diagnostics 0.1 $231k 42k 5.54
BioCryst Pharmaceuticals (BCRX) 0.1 $204k 25k 8.16
Novavax 0.1 $138k 250k 0.55